共 50 条
- [1] Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority studyBRITISH JOURNAL OF PSYCHIATRY, 2014, 205 (02) : 135 - 144Fleischhacker, W. WolfgangSanchez, RaymondPerry, Pamela P.Jin, NaPeters-Strickland, TimothyJohnson, Brian R.Baker, Ross A.Eramo, AnnaMcQuade, Robert D.Carson, William H.Walling, DavidKane, John M.
- [2] Aripiprazole once-monthly for schizophrenia: a double-blind, randomised, non-inferiority study versus oral aripiprazoleEUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S473 - S474Peters-Strickland, T.Fleischhacker, W. W.Sanchez, R.Jin, N.Baker, R. A.Johnson, B.Loze, J. Y.McQuade, R. D.Carson, W. H.Kane, J. M.
- [3] Personal and social performance in schizophrenia: double-blind, non-inferiority study of once-monthly vs oral aripiprazoleEUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S474 - S475Fleischhacker, W. W.Sanchez, R.Jin, N.Peters-Strickland, T.Johnson, B. R.Eramo, A.Loze, J. Y.McQuade, R. D.Carson, W. H.Kane, J.
- [4] Efficacy and safety of aripiprazole once-monthly in Asian patients with schizophrenia: A multicenter, randomized, double-blind, non-inferiority study versus oral aripiprazoleSCHIZOPHRENIA RESEARCH, 2015, 161 (2-3) : 421 - 428Ishigooka, JunNakamura, JunFujii, YasuoIwata, NakaoKishimoto, ToshifumiIyo, MasaomiUchimura, NaohisaNishimura, RyojiShimizu, Naoaki
- [5] Efficacy and safety of aripiprazole once-monthly versus oral aripiprazole in Chinese patients with acute schizophrenia: a multicenter, randomized, double-blind, non-inferiority studyPsychopharmacology, 2022, 239 : 243 - 251Le XiaoQian ZhaoAn-ning LiJushui SunBin WuLina WangHonggeng ZhangRuiling ZhangKeqing LiXiaojin XuTiebang LiuWenshun ZhangShiping XieXiufeng XuYunlong TanKerang ZhangHongyan ZhangNianhong GuanMingji XianMotomichi UkiGang Wang
- [6] Efficacy and safety of aripiprazole once-monthly versus oral aripiprazole in Chinese patients with acute schizophrenia: a multicenter, randomized, double-blind, non-inferiority studyPSYCHOPHARMACOLOGY, 2022, 239 (01) : 243 - 251Xiao, LeZhao, QianLi, An-ningSun, JushuiWu, BinWang, LinaZhang, HonggengZhang, RuilingLi, KeqingXu, XiaojinLiu, TiebangZhang, WenshunXie, ShipingXu, XiufengTan, YunlongZhang, KerangZhang, HongyanGuan, NianhongXian, MingjiUki, MotomichiWang, Gang
- [7] Efficacy of aripirpazole once-monthly in Asian patients with schizophrenia: Secondary efficacy outcomes in a multicenter, randomized, double-blind, non-inferiority study versus oral aripiprazoleINTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 62 - 62Ishigooka, J.Nakamura, J.Shimizu, N.
- [8] Aripiprazole Once-Monthly in the Acute Treatment of Schizophrenia: Findings From a 12-Week, Randomized, Double-Blind, Placebo-Controlled StudyJOURNAL OF CLINICAL PSYCHIATRY, 2014, 75 (11) : 1254 - 1260Kane, John M.Peters-Strickland, TimothyBaker, Ross A.Hertel, PeterEramo, AnnaJin, NaPerry, Pamela P.Gara, MichelleMcQuade, Robert D.Carson, William H.Sanchez, Raymond
- [9] Safety and Effectiveness of Aripiprazole Once-monthly for the Treatment of Schizophrenia: A Pooled Analysis of Two Double-blind, Randomized, Controlled Trials (246 and 247)NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S394 - S395Fleischhacker, W. WolfgangSanchez, RaymondLan-Feng, TsaiPeters-Strickland, TimothyBaker, Ross A.Eramo, AnnaKostic, DusanKane, John
- [10] ALL-CAUSE DISCONTINUATION AND SAFETY OF ARIPIPRAZOLE ONCE-MONTHLY FOR THE TREATMENT OF SCHIZOPHRENIA: A POOLED ANALYSIS OF TWO DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIALSSCHIZOPHRENIA RESEARCH, 2014, 153 : S174 - S174Eramo, AnnaFleischhacker, W. WolfgangSanchez, RaymondTsai, Lan-FengPeters-Strickland, Timothy S.Baker, Ross A.Kostic, DusanKane, John M.